OHSU
Return to Listing

1 result(s) for NeuVax

PI Name Protocol # Title
Kathleen Kemmer IRB00008158 PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program